Evidence map›Paper›PMID 29750783›Full record

ArticlePloS one2018

Engineering bacterial motility towards hydrogen-peroxide.

Chelsea Virgile, Pricila Hauk, Hsuan-Chen Wu, Wu Shang, Chen-Yu Tsao, Gregory F Payne, William E Bentley

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Machine learning-based inverse design for electrochemically controlled microscopic gradients of OProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Can thiol-based redox systems be utilized as parts for synthetic biology applications?Redox report : communications in free radical research · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Redox Is a Global Biodevice Information Processing Modality.Proceedings of the IEEE. Institute of Electrical and Electronics Engineers · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Chelsea VirgileInstitute for Bioscience and Biotechnology Research, University of Maryland, College Park, Maryland, United States of America.
Pricila HaukInstitute for Bioscience and Biotechnology Research, University of Maryland, College Park, Maryland, United States of America.
Hsuan-Chen WuDepartment of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan.
Wu ShangInstitute for Bioscience and Biotechnology Research, University of Maryland, College Park, Maryland, United States of America.
Chen-Yu TsaoInstitute for Bioscience and Biotechnology Research, University of Maryland, College Park, Maryland, United States of America.
Gregory F PayneInstitute for Bioscience and Biotechnology Research, University of Maryland, College Park, Maryland, United States of America.
William E BentleyInstitute for Bioscience and Biotechnology Research, University of Maryland, College Park, Maryland, United States of America.ORCID 0000-0002-4855-7866
University of Maryland, College Park · USNational Taiwan University · TW

Funding

Accessing molecular communication via synthetic biology and microelectronics – gut on a chip modelR21EB024102 · NIBIB · UNIV OF MARYLAND, COLLEGE PARK · PI BENTLEY, WILLIAM E. · 2017 to 2018
$412k
NIBIB NIH HHS R21 EB024102
6 · The paper itself

Abstract

Synthetic biologists construct innovative genetic/biological systems to treat environmental, energy, and health problems. Many systems employ rewired cells for non-native product synthesis, while a few have employed the rewired cells as 'smart' devices with programmable function. Building on the latter, we developed a genetic construct to control and direct bacterial motility towards hydrogen peroxide, one of the body's immune response signaling molecules. A motivation for this work is the creation of cells that can target and autonomously treat disease, the latter signaled by hydrogen peroxide release. Bacteria naturally move towards a variety of molecular cues (e.g., nutrients) in the process of chemotaxis. In this work, we engineered bacteria to recognize and move towards hydrogen peroxide, a non-native chemoattractant and potential toxin. Our system exploits oxyRS, the native oxidative stress regulon of E. coli. We first demonstrated H2O2-mediated upregulation motility regulator, CheZ. Using transwell assays, we showed a two-fold increase in net motility towards H2O2. Then, using a 2D cell tracking system, we quantified bacterial motility descriptors including velocity, % running (of tumble/run motions), and a dynamic net directionality towards the molecular cue. In CheZ mutants, we found that increased H2O2 concentration (0-200 μM) and induction time resulted in increased running speeds, ultimately reaching the native E. coli wild-type speed of ~22 μm/s with a ~45-65% ratio of running to tumbling. Finally, using a microfluidic device with stable H2O2 gradients, we characterized responses and the potential for "programmed" directionality towards H2O2 in quiescent fluids. Overall, the synthetic biology framework and tracking analysis in this work will provide a framework for investigating controlled motility of E. coli and other 'smart' probiotics for signal-directed treatment.

Indexed as

Escherichia coli K12Escherichia coli ProteinsMethyl-Accepting Chemotaxis ProteinsMicroorganisms, Genetically-ModifiedMutationRepressor ProteinsGenetic EngineeringHydrogen PeroxideRNA, Small UntranslatedcheZ protein, E coliEscherichia coli ProteinsHydrogen PeroxideMethyl-Accepting Chemotaxis ProteinsoxyR protein, E colioxyS small RNA, E coliRepressor ProteinsRNA, Small Untranslated

Identifiers

PMID29750783
PMCPMC5947916
OpenAlexW2802855191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.